Antibiotics Webinar | Structural Aspects of AMPs and Antimicrobials Ⅲ
Antibiotics Webinar | Structural Aspects of AMPs and Antimicrobials Ⅲ
Part of the Antibiotics Webinar series
15 December 2025
Antimicrobial Peptides, Antimicrobial Agent, Antibiotic Resistance, Structure Activity Relationship SAR
Welcome from the Chair
10th Antibiotics Webinar
Structural Aspects of AMPs and Antimicrobials Ⅲ
Dear colleagues,
It is a pleasure to welcome you to this webinar, part of a series of online presentations, entitled “Structural Aspects of AMPs and Antimicrobials Ⅲ”.
Antimicrobial peptides or AMPs are natural and/or synthetic peptides with inhibitory activities against micro-organisms, including bacteria, fungi, and viruses.
AMPs are very diverse in terms of sequence, mechanism of synthesis/maturation, and structures. The goal of this series of webinars on “Structural Aspects of AMPs and Antimicrobials” is to present recent and important findings regarding the discovery and characterization of AMPs.
For today’s webinar, I am happy and honored to welcome Dr. Yanyan Li and Prof Octavio Franco. Dr. Li is a principal investigator and group leader in the French National Center for Scientific Research (CNRS). She obtained her PhD in chemistry from the University of Cambridge, UK, and received postdoctoral training at the Institut de Chimie des Substances Naturelles (ICSN), France, and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Germany. Her main research interest is focused on the discovery, biosynthesis, and mechanism of action studies of bacterial antimicrobial peptides. Her presentation today will be about the “Mode of action of antibacterial ribosomally synthesized and post-translationally modified peptides (RiPPs)”. Prof Franco is a professor and coordinator of the Biotechnology Program at Universidade Católica Dom Bosco. He holds a PhD in Biological Sciences from the University of Brasília and completed postdoctoral training at Embrapa and the University of Edinburgh. A CNPq Level 1A Researcher, he has published over 550 scientific papers in leading journals and holds nearly 40 patents, including the anti-aging product OS-1. He co-founded Peptidus, Lumis, and SO Biotech, focusing on biotechnology and health. He has supervised over 120 graduate students and is actively involved in science communication through lectures, media, and social media platforms. His presentation today will be about the “Generation of novel antibiotics from natural products by using digital platforms”.
Date: 15 December 2025
Time: 2:00 pm CET | 8:00 am EST
Webinar ID: 812 1768 8919
Webinar Secretariat: journal.webinar@mdpi.com
Registration
This is a FREE webinar. After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Certificates of attendance will be delivered to those who attend the live webinar.
Can’t attend? Register anyway and we’ll let you know when the recording is available to watch.
Event Chair
Dr. Marc Maresca is researcher at the Aix-Marseille Université. He received his P.h.D in Biochemistry at the Université Paul Cézanne (France, 2003) working on food contaminants named mycotoxins. He is currently working at the Institut des Sciences Moléculaires de Marseille (ISM2) UMR-AMU-CNRS 7313 and his research aims to identify and develop new molecules – natural, synthetic, or bio-inspired – with therapeutic values, including antimicrobial peptides and their mimics as well as on plant molecules derivatives.
Keynote Speakers
Laboratory Molecules of Communication and Adaptation of Microorganisms (MCAM), French National Center for Scientific Research (CNRS), National Museum of Natural History (MNHN), France
Dr. Yanyan Li is a principal investigator and group leader in the French National Center for Scientific Research (CNRS). She obtained her Ph.D in chemistry from the University of Cambridge, UK, and received postdoctoral training at the Institut de Chimie des Substances Naturelles (ICSN), France and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Germany. Her main research interest is focused on the discovery, biosynthesis and mechanism of action studies of bacterial antimicrobial peptides.
1. Center for Proteomics and Biochemical Analysis, Postgraduate Program in Genomic Sciences and Biotechnology, Catholic University of Brasília, Brazil; 2. Postgraduate Program in Biotechnology, S-Inova Biotech, Dom Bosco Catholic University, Brazil
Octávio Luiz Franco is a professor and coordinator of the Biotechnology Program at Universidade Católica Dom Bosco. He holds a PhD in Biological Sciences from the University of Brasília and completed postdoctoral training at Embrapa and the University of Edinburgh. A CNPq Level 1A Researcher, he has published over 550 scientific papers in leading journals and holds nearly 40 patents, including the anti-aging product OS-1. He co-founded Peptidus, Lumis, and SO Biotech, focusing on biotechnology and health. He has supervised over 120 graduate students and is actively involved in science communication through lectures, media, and social media platforms.
Program
|
Speaker |
Presentation Title |
Time in CET |
Time in EST |
|
Dr. Marc Maresca |
Chair Introduction |
2:00 – 2:10 pm |
8:00 – 8:10 am |
|
Dr. Yanyan Li |
Mode of Action of Antibacterial Ribosomally Synthesized and Post-Translationally Modified Peptides (Ripps) |
2:10 – 2:35 pm |
8:10 – 8:35 am |
|
Prof. Dr. Octávio Luiz Franco |
Generation of Novel Antibiotics From Natural Products by Using Digital Platforms |
2:35 – 3:00 pm |
8:35 – 9:00 am |
|
Q&A |
3:00 – 3:10 pm |
9:00 – 9:10 am |
|
|
Dr. Marc Maresca |
Closing of Webinar |
3:10 – 3:20 am |
9:10 – 9:20 am |
Relevant Topical Collection
Editorial Board Members' Collection Series: Structural Aspects of AMPs and Antimicrobials
Edited by J. Michael Conlon, Marc Maresca, Bong-Jin Lee and Aurélie Tasiemski
https://www.mdpi.com/journal/antibiotics/topical_collections/DN4VI999FP
Sponsors and Partners
Organizers
